R&D Systems™ Recombinant Human CART Protein

Description

Recombinant Protein

Measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons. Recombinant Human CART, immobilized at 5.0 μg/mL on a 96 well plate, is able to significantly enhance neurite outgrowth.

Specifications

• Accession Number: Q16568.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in HCl.
• Gene ID (Entrez): 9607
• Molecular Weight (g/mol): M.W.-observed: 8-10 kDa, reducing conditions., M.W.-theroretical: 9 kDa
• Quantity: 50 μg
• Source: E. coli-derived human CART protein Ala37-Leu116
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: CART prepropeptide, CARTcocaine and amphetamine regulated transcript, CARTPT, cocaine- and amphetamine-regulated transcript protein
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in 4 mM HCl.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: CART/CARTPT